Ritholtz Wealth Management purchased a new position in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 27,552 shares of the health services provider's stock, valued at approximately $460,000.
Other hedge funds have also bought and sold shares of the company. LPL Financial LLC raised its stake in shares of Select Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 31,441 shares of the health services provider's stock valued at $593,000 after buying an additional 619 shares during the period. Vista Finance LLC raised its stake in shares of Select Medical by 7.0% during the 1st quarter. Vista Finance LLC now owns 10,969 shares of the health services provider's stock valued at $183,000 after purchasing an additional 716 shares during the period. Net Worth Advisory Group raised its stake in shares of Select Medical by 6.4% during the 1st quarter. Net Worth Advisory Group now owns 14,045 shares of the health services provider's stock valued at $235,000 after purchasing an additional 846 shares during the period. Bank of Montreal Can raised its stake in shares of Select Medical by 4.5% during the 4th quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider's stock valued at $378,000 after purchasing an additional 867 shares during the period. Finally, Sterling Capital Management LLC raised its stake in shares of Select Medical by 9.5% during the 4th quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider's stock valued at $213,000 after purchasing an additional 978 shares during the period. 89.48% of the stock is currently owned by institutional investors.
Insider Activity at Select Medical
In other Select Medical news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the firm's stock in a transaction dated Monday, May 5th. The stock was purchased at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the completion of the purchase, the director now directly owns 65,089 shares of the company's stock, valued at $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO David S. Chernow sold 225,000 shares of the business's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer now owns 714,516 shares of the company's stock, valued at $12,861,288. This represents a 23.95% decrease in their position. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by corporate insiders.
Select Medical Trading Up 0.1%
SEM traded up $0.02 on Monday, hitting $14.86. 1,085,044 shares of the company were exchanged, compared to its average volume of 971,211. The firm has a fifty day simple moving average of $15.49 and a two-hundred day simple moving average of $17.32. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.16 and a current ratio of 1.16. Select Medical Holdings Corporation has a 12 month low of $14.03 and a 12 month high of $40.98. The stock has a market capitalization of $1.91 billion, a PE ratio of 11.09, a price-to-earnings-growth ratio of 0.79 and a beta of 1.34.
Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a return on equity of 11.04% and a net margin of 2.81%. Select Medical's revenue was down 24.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.75 earnings per share. Sell-side analysts expect that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.
Select Medical announced that its board has initiated a stock buyback plan on Thursday, May 1st that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to buy up to 42.6% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board believes its stock is undervalued.
Select Medical Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were given a dividend of $0.0625 per share. The ex-dividend date was Thursday, May 15th. This represents a $0.25 annualized dividend and a dividend yield of 1.68%. Select Medical's dividend payout ratio is presently 18.66%.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. Royal Bank Of Canada decreased their price objective on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 7th. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price on the stock. Finally, Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price on the stock in a research note on Monday, February 24th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $26.00.
Check Out Our Latest Report on Select Medical
Select Medical Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.